An integrated understanding of the physiological response to elevated extracellular phosphate

Journal of Cellular Physiology

Volumn 228, Issue 7, 2013, Pages 1536-1550

  Camalier, Corinne E ^a   Yi, Ming ^b   Yu, Li Rong ^b   Hood, Brian L ^c   Conrads, Kelly A ^d   Lee, Young Jae ^a,e   Lin, Yiming ^a   Garneys, Laura M ^a   Bouloux, Gary F ^a   Young, Matthew R ^d   Veenstra, Timothy D ^b   Stephens, Robert M ^b   Colburn, Nancy H ^d   Conrads, Thomas P ^c   Beck, George R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAIC FREDERICK INC   (United States)

^c BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Jeju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; FIBROBLAST GROWTH FACTOR RECEPTOR; PHOSPHATE; PROTEIN C FOS;

ADULT; ANGIOGENESIS; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTEGRATION; MALE; MESENCHYMAL STROMA CELL; MITOGENICITY; MOUSE; NONHUMAN; ONCOGENE N RAS; OSTEOBLAST; OXIDATIVE PHOSPHORYLATION; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEOMICS; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

3T3 CELLS; ADENOSINE TRIPHOSPHATE; ANIMALS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; EXTRACELLULAR SPACE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GENES, FOS; GENES, IMMEDIATE-EARLY; GENES, RAS; GTP-BINDING PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; PHOSPHATES; PROMOTER REGIONS, GENETIC; PROTEINS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 84875524994     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24312     Document Type: Article

References (118)

1. Addison WN, Azari F, Sorensen ES, Kaartinen MT, McKee MD. 2007. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem 282: 15872-15883.
2. Arenander AT, Lim RW, Varnum BC, Cole R, de Vellis J, Herschman HR. 1989. TIS gene expression in cultured rat astrocytes: Multiple pathways of induction by mitogens. J Neurosci Res 23: 257-265.
3. Barsh GS, Greenberg DB, Cunningham DD. 1977. Phosphate uptake and control of fibroblasts growth. J Cell Physiol 92: 115-128.
4. Beck GR, Jr. 2003. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 90: 234-243.
5. Beck GR, Jr., Knecht N. 2003. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 278: 41921-41929.
6. Beck GR, Jr., Sullivan EC, Moran E, Zerler B. 1998. Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem 68: 269-280.
7. Beck GR, Jr., Moran E, Knecht N. 2003. Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 288: 288-300.
8. Beck L, Leroy C, Salaun C, Margall-Ducos G, Desdouets C, Friedlander G. 2009. Identification of a novel function of PiT1 critical for cell proliferation and independent of its phosphate transport activity. J Biol Chem 284: 31363-31374.
9. Beck GR, Jr., Khazai NB, Bouloux GF, Camalier CE, Lin Y, Garneys LM, Siqueira J, Peng L, Pasquel F, Umpierrez D, Smiley D, Umpierrez GE. 2012. The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes. Transl Res DOI: 10.1016/j.trsl.2012.08.006 [Epub ahead of print].
10. Beenken A, Mohammadi M. 2009. The FGF family: Biology, pathophysiology and therapy. Nat Rev Drug Discov 8: 235-253.
11. Bergwitz C, Rasmussen MD, DeRobertis C, Wee MJ, Sinha S, Chen HH, Huang J, Perrimon N. 2012. Roles of major facilitator superfamily transporters in phosphate response in Drosophila. PLoS ONE 7: e31730.
12. Bravo R, Burckhardt J, Curran T, Muller R. 1986. Expression of c-fos in NIH3T3 cells is very low but inducible throughout the cell cycle. EMBO J 5: 695-700.
13. Byskov K, Jensen N, Kongsfelt IB, Wielsoe M, Pedersen LE, Haldrup C, Pedersen L. 2012. Regulation of cell proliferation and cell density by the inorganic phosphate transporter PiT1. Cell Div 7: 7.
14. Camalier CE, Young MR, Bobe G, Perella CM, Colburn NH, Beck GR, Jr. 2010. Elevated phosphate activates N-Ras and promotes cell transformation and skin tumorigenesis. Cancer Prev Res (Phila Pa) 3: 359-370.
15. Cecil DL, Rose DM, Terkeltaub R, Liu-Bryan R. 2005. Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytes. Arthritis Rheum 52: 144-154.
16. Chang SH, Yu KN, Lee YS, An GH, Beck GR, Jr., Colburn NH, Lee KH, Cho MH. 2006. Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells. Am J Respir Cell Mol Biol 35: 528-539.
17. Cochran BH, Reffel AC, Stiles CD. 1983. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33: 939-947.
18. Collins JF, Bai L, Ghishan FK. 2004. The SLC20 family of proteins: Dual functions as sodium-phosphate cotransporters and viral receptors. Pflugers Arch 447: 647-652.
19. Conrads KA, Yu LR, Lucas DA, Zhou M, Chan KC, Simpson KA, Schaefer CF, Issaq HJ, Veenstra TD, Beck GR, Jr., Conrads TP. 2004. Quantitative proteomic analysis of inorganic phosphate-induced murine MC3T3-E1 osteoblast cells. Electrophoresis 25: 1342-1352.
20. Conrads KA, Yi M, Simpson KA, Lucas DA, Camalier CE, Yu LR, Veenstra TD, Stephens RM, Conrads TP, Beck GR, Jr. 2005. A combined proteome and microarray investigation of inorganic phosphate-induced pre-osteoblast cells. Mol Cell Proteomics 4: 1284-1296.
21. Cunningham DD, Pardee AB. 1969. Transport changes rapidly initiated by serum addition to "contact inhibited" 3T3 cells. Proc Natl Acad Sci USA 64: 1049-1056.
22. Curran T, Franza BR, Jr. 1988. Fos and Jun: The AP-1 connection. Cell 55: 395-397.
23. de Asua LJ, Rozengurt E, Dulbecco R. 1974. Kinetics of early changes in phosphate and uridine transport and cyclic AMP levels stimulated by serum in density-inhibited 3T3 cells. Proc Natl Acad Sci USA 71: 96-98.
24. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB, Sr., Gaziano JM Vasan RS. 2007. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167: 879-885.
25. Du X, Xie Y, Xian CJ, Chen L. 2012. Role of FGFs/FGFRs in skeletal development and bone regeneration. J Cell Physiol 227: 3731-3743.
26. Engstrom W, Zetterberg A. 1983. Phosphate and the regulation of DNA replication in normal and virus-transformed 3T3 cells. Biochem J 214: 695-702.
27. Eswarakumar VP, Lax I, Schlessinger J. 2005. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149.
28. Ferro CJ, Chue CD, Steeds RP, Townend JN. 2009. Is lowering phosphate exposure the key to preventing arterial stiffening with age? Heart 95: 1770-1772.
29. Festing MH, Speer MY, Yang HY, Giachelli CM. 2009. Generation of mouse conditional and null alleles of the type III sodium-dependent phosphate cotransporter PiT-1. Genesis 47: 858-863.
30. Fisher LW, Stubbs JT, III, Young MF. 1995. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl 266: 61-65.
31. Foster BL, Nociti FH, Jr., Swanson EC, Matsa-Dunn D, Berry JE, Cupp CJ, Zhang P, Somerman MJ. 2006. Regulation of cementoblast gene expression by inorganic phosphate in vitro. Calcif Tissue Int 78: 103-112.
32. Fujita T, Meguro T, Izumo N, Yasutomi C, Fukuyama R, Nakamuta H, Koida M. 2001. Phosphate stimulates differentiation and mineralization of the chondroprogenitor clone ATDC5. Jpn J Pharmacol 85: 278-281.
33. Giachelli CM. 2003. Vascular calcification: In vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 14: S300-S304.
34. Giachelli CM. 2009. The emerging role of phosphate in vascular calcification. Kidney Int 75: 890-897.
35. Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M. 2004. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res 64: 236-242.
36. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK. 2011. Normalization of the vasculature for treatment of cancer and other diseases. Physiolog Rev 91: 1071-1121.
37. Golub EE. 2011. Biomineralization and matrix vesicles in biology and pathology. Semin Immunopathol 33: 409-417.
38. Gotoh N. 2008. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci 99: 1319-1325.
39. Greenberg ME, Greene LA, Ziff EB. 1985. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J Biol Chem 260: 14101-14110.
40. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999.
41. Hankenson KD, Dishowitz M, Gray C, Schenker M. 2011. Angiogenesis in bone regeneration. Injury 42: 556-561.
42. Herschman HR. 1991. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60: 281-319.
43. Hilborn DA. 1976. Serum stimulation of phosphate uptake into 3T3 cells. J Cell Physiol 87: 111-121.
44. Holley RW, Kiernan JA. 1974. Control of the initiation of DNA synthesis in 3T3 cells: Low-molecular weight nutrients. Proc Natl Acad Sci USA 71: 2942-2945.
45. Huttunen MM, Pietila PE, Viljakainen HT, Lamberg-Allardt CJ. 2006. Prolonged increase in dietary phosphate intake alters bone mineralization in adult male rats. J Nutr Biochem 17: 479-484.
46. Huttunen MM, Tillman I, Viljakainen HT, Tuukkanen J, Peng Z, Pekkinen M, Lamberg-Allardt CJ. 2007. High dietary phosphate intake reduces bone strength in the growing rat skeleton. J Bone Miner Res 22: 83-92.
47. Ito M, Sakai Y, Furumoto M, Segawa H, Haito S, Yamanaka S, Nakamura R, Kuwahata M, Miyamoto K. 2005. Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. Am J Physiol Endocrinol Metabol 288: E1101-E1109.
48. Ji QS, Mulvihill MJ, Rosenfeld-Franklin M, Cooke A, Feng L, Mak G, O'Connor M, Yao Y, Pirritt C, Buck E, Eyzaguirre A, Arnold LD, Gibson NW, Pachter JA. 2007. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo. Mol Cancer Ther 6: 2158-2167.
49. Jin H, Hwang SK, Yu K, Anderson HK, Lee YS, Lee KH, Prats AC, Morello D, Beck GR, Jr., Cho MH. 2006. A high inorganic phosphate diet perturbs brain growth, alters Akt-ERK signaling, and results in changes in cap-dependent translation. Toxicol Sci 90: 221-229.
50. Jin H, Chang SH, Xu CX, Shin JY, Chung YS, Park SJ, Lee YS, An GH, Lee KH, Cho MH. 2007. High dietary inorganic phosphate affects lung through altering protein translation, cell cycle, and angiogenesis in developing mice. Toxicol Sci 100: 215-223.
51. Jin H, Xu CX, Lim HT, Park SJ, Shin JY, Chung YS, Park SC, Chang SH, Youn HJ, Lee KH, Lee YS, Ha YC, Chae CH, Beck GR, Jr., Cho MH. 2009. High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling. Am J Respir Crit Care Med 179: 59-68.
52. Johnson K, Goding J, Van Etten D, Sali A, Hu SI, Farley D, Krug H, Hessle L, Millan JL, Terkeltaub R. 2003. Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res 18: 994-1004.
53. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. 2000. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17.
54. Julien M, Magne D, Masson M, Rolli-Derkinderen M, Chassande O, Cario-Toumaniantz C, Cherel Y, Weiss P, Guicheux J. 2007. Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway. Endocrinology 148: 530-537.
55. Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K. 2003. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. J Cell Physiol 196: 180-189.
56. Kido S, Miyamoto K, Mizobuchi H, Taketani Y, Ohkido I, Ogawa N, Kaneko Y, Harashima S, Takeda E. 1999. Identification of regulatory sequences and binding proteins in the type II sodium/phosphate cotransporter NPT2 gene responsive to dietary phosphate. J Biol Chem 274: 28256-28263.
57. Kim DW, Cheriyath V, Roy AL, Cochran BH. 1998. TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. Mol Cell Biol 18: 3310-3320.
58. Kimata M, Michigami T, Tachikawa K, Okada T, Koshimizu T, Yamazaki M, Kogo M, Ozono K. 2010. Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway. Bone 47: 938-947.
59. Koshihara M, Katsumata S, Uehara M, Suzuki K. 2005a. Effects of dietary phosphorus intake on bone mineralization and calcium absorption in adult female rats. Biosci Biotechnol Biochem 69: 1025-1028.
60. Koshihara M, Masuyama R, Uehara M, Suzuki K. 2005b. Reduction in dietary calcium/phosphorus ratio reduces bone mass and strength in ovariectomized rats enhancing bone turnover. Biosci Biotechnol Biochem 69: 1970-1973.
61. Kume T. 2008. Foxc2 transcription factor: A newly described regulator of angiogenesis. Trends Cardiovasc Med 18: 224-228.
62. Lammi J, Huppunen J, Aarnisalo P. 2004. Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Mol Endocrinol 18: 1546-1557.
63. Lau LF, Nathans D. 1985. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. Embo J 4: 3145-3151.
64. Li X, Yang HY, Giachelli CM. 2006. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98: 905-912.
65. Lian JB, Stein GS, Bortell R, Owen TA. 1991. Phenotype suppression: A postulated molecular mechanism for mediating the relationship of proliferation and differentiation by Fos/Jun interactions at AP-1 sites in steroid responsive promoter elements of tissue-specific genes. J Cell Biochem 45: 9-14.
66. Lim RW, Varnum BC, Herschman HR. 1987. Cloning of tetradecanoyl phorbol ester-induced "primary response" sequences and their expression in density-arrested Swiss 3T3 cells and a TPA non-proliferative variant. Oncogene 1: 263-270.
67. Lundquist P, Ritchie HH, Moore K, Lundgren T, Linde A. 2002. Phosphate and calcium uptake by rat odontoblast-like MRPC-1 cells concomitant with mineralization. J Bone Miner Res 17: 1801-1813.
68. Lundquist P, Murer H, Biber J. 2007. Type II Na+-Pi cotransporters in osteoblast mineral formation: Regulation by inorganic phosphate. Cell Physiol Biochem 19: 43-56.
69. Malumbres M, Pellicer A. 1998. RAS pathways to cell cycle control and cell transformation. Front Biosci 3: d887-d912.
70. Mansfield K, Teixeira CC, Adams CS, Shapiro IM. 2001. Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism. Bone 28: 1-8.
71. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA. 2008. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 19: 1092-1105.
72. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS. 1996. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation. Endocrinology 137: 4398-4408.
73. Meng Z, Camalier CE, Lucas DA, Veenstra TD, Beck GR, Jr., Conrads TP. 2006. Probing early growth response 1 interacting proteins at the active promoter in osteoblast cells using oligoprecipitation and mass spectrometry. J Proteome Res 5: 1931-1939.
74. Mirams M, Robinson BG, Mason RS, Nelson AE. 2004. Bone as a source of FG F23: Regulation by phosphate. Bone 35: 1192-1199.
75. Mozar A, Haren N, Chasseraud M, Louvet L, Maziere C, Wattel A, Mentaverri R, Morliere P, Kamel S, Brazier M, Maziere JC, Massy ZA. 2008. High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells. J Cell Physiol 215: 47-54.
76. Mulvihill MJ, Ji QS, Coate HR, Cooke A, Dong H, Feng L, Foreman K, Rosenfeld-Franklin M, Honda A, Mak G, Mulvihill KM, Nigro AI, O'Connor M, Pirrit C, Steinig AG, Siu K, Stolz KM, Sun Y, Tavares PA, Yao Y, Gibson NW. 2008. Novel 2-phenylquinolin-7-yl-derived imidazo[1, 5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors. Bioorg Med Chem 16: 1359-1375.
77. Murai K, Treisman R. 2002. Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1. Mol Cell Biol 22: 7083-7092.
78. Nakamura K, Taguchi E, Miura T, Yamamoto A, Takahashi K, Bichat F, Guilbaud N, Hasegawa K, Kubo K, Fujiwara Y, Suzuki R, Kubo K, Shibuya M, Isae T. 2006. KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. Cancer Res 66: 9134-9142.
79. Onufrak SJ, Bellasi A, Shaw LJ, Herzog CA, Cardarelli F, Wilson PW, Vaccarino V, Raggi P. 2008. Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis 199: 424-431.
80. Orfanidou T, Malizos KN, Varitimidis S, Tsezou A. 2012. 1, 25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes. Exp Biol Med 237: 241-253.
81. Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome Biol 2: REVIEWS3005.
82. Owen TA, Bortell R, Yocum SA, Smock SL, Zhang M, Abate C, Shalhoub V, Aronin N, Wright KL, van Wijnen AJ, Stein JL, Curran T, Lian JB, Stein GS. 1990. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: Model for phenotype suppression of transcription. Proc Natl Acad Sci USA 87: 9990-9994.
83. Panek RL, Lu GH, Dahring TK, Batley BL, Connolly C, Hamby JM, Brown KJ. 1998. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. J Pharmacol Exp Ther 286: 569-577.
84. Quarles LD. 2012. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 8: 276-286.
85. Rincon M, Flavell RA. 1994. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. Embo J 13: 4370-4381.
86. Roussanne MC, Lieberherr M, Souberbielle JC, Sarfati E, Drueke T, Bourdeau A. 2001. Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate. Eur J Clin Invest 31: 610-616.
87. Rubin H, Chu BM. 1984. Solute concentration effects on the expression of cellular heterogeneity of anchorage-independent growth among spontaneously transformed BALB/c3T3 cells. In Vitro 20: 585-596.
88. Rubin H, Sanui H. 1977. Complexes of inorganic pyrophosphate, orthophosphate, and calcium as stimulants of 3T3 cell multiplication. Proc Natl Acad Sci USA 74: 5026-5030.
89. Rubin J, Murphy TC, Rahnert J, Song H, Nanes MS, Greenfield EM, Jo H, Fan X. 2006. Mechanical inhibition of RANKL expression is regulated by H-Ras-GTPase. J Biol Chem 281: 1412-1418.
90. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B. 2004. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23: 421-432.
91. Stromberg T, Ekman S, Girnita L, Dimberg LY, Larsson O, Axelson M, Lennartsson J, Hellman U, Carlson K, Osterborg A, Vanderkerken K, Nilsson K, Jernberg-Wiklund H. 2006. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood 107: 669-678.
92. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. 1983. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96: 191-198.
93. Suzukawa K, Weber TJ, Colburn NH. 2002. AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environ Health Perspect 110: 865-870.
94. Suzuki A, Palmer G, Bonjour JP, Caverzasio J. 2000. Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells. J Bone Miner Res 15: 95-102.
95. Suzuki A, Ghayor C, Guicheux J, Magne D, Quillard S, Kakita A, Ono Y, Miura Y, Oiso Y, Itoh M, Caverzasio J. 2006. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res 21: 674-683.
96. Takeyama S, Yoshimura Y, Deyama Y, Sugawara Y, Fukuda H, Matsumoto A. 2001. Phosphate decreases osteoclastogenesis in coculture of osteoblast and bone marrow. Biochem Biophys Res Commun 282: 798-802.
97. Tanaka Y, Nakayamada S, Fujimoto H, Okada Y, Umehara H, Kataoka T, Minami Y. 2002. H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts. J Biol Chem 277: 21446-21452.
98. Teixeira CE, Teixeira SA, Antunes E, De Nucci G. 2001. The role of nitric oxide on the relaxations of rabbit corpus cavernosum induced by Androctonus australis and Buthotus judaicus scorpion venoms. Toxicon 39: 633-639.
99. Tenenhouse HS. 2005. Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter. Annu Rev Nutr 25: 197-214.
100. Tenenhouse HS. 2007. Phosphate transport: Molecular basis, regulation and pathophysiology. J Steroid Biochem Mol Biol 103: 572-577.
101. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. 2005. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633.
102. Treisman R. 1986. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46: 567-574.
103. Treisman R. 1987. Identification and purification of a polypeptide that binds to the c-fos serum response element. Embo J 6: 2711-2717.
104. Treisman R, Marais R, Wynne J. 1992. Spatial flexibility in ternary complexes between SRF and its accessory proteins. Embo J 11: 4631-4640.
105. Wada K, Mizuno M, Komori T, Tamura M. 2004. Extracellular inorganic phosphate regulates gibbon ape leukemia virus receptor-2/phosphate transporter mRNA expression in rat bone marrow stromal cells. J Cell Physiol 198: 40-47.
106. Wagner EF. 2002. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61: ii40-ii42.
107. Weber MJ, Edlin G. 1971. Phosphate transport, nucleotide pools, and ribonucleic acid synthesis in growing and in density-inhibited 3T3 cells. J Biol Chem 246: 1828-1833.
108. Werner A, Dehmelt L, Nalbant P. 1998. Na+-dependent phosphate cotransporters: The NaPi protein families. J Exp Biol 201: 3135-3142.
109. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA. 2003. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22: 6267-6276.
110. Xiao Z, Camalier CE, Nagashima K, Chan KC, Lucas DA, de la Cruz MJ, Gignac M, Lockett S, Issaq HJ, Veenstra TD, Conrads TP, Beck GR, Jr. 2007. Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts. J Cell Physiol 210: 325-335.
111. Xu CX, Jin H, Lim HT, Kim JE, Shin JY, Lee ES, Chung YS, Lee YS, Beck G, Jr., Lee KH, Cho MH. 2008. High dietary inorganic phosphate enhances cap-dependent protein translation, cell-cycle progression, and angiogenesis in the livers of young mice. Am J Physiol Gastrointest Liver Physiol 295: G654-G663.
112. Yamazaki M, Ozono K, Okada T, Tachikawa K, Kondou H, Ohata Y, Michigami T. 2010. Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells. J Cell Biochem 111: 1210-1221.
113. Yates AJ, Oreffo RO, Mayor K, Mundy GR. 1991. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts. J Bone Miner Res 6: 473-478.
114. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM. 2006. WholePathwayScope: A comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinform 7: 30.
115. Yi M, Mudunuri U, Che A, Stephens RM. 2009. Seeking unique and common biological themes in multiple gene lists or datasets: Pathway pattern extraction pipeline for pathway-level comparative analysis. BMC Bioinform 10: 200.
116. Yoshiko Y, Candeliere GA, Maeda N, Aubin JE. 2007. Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 27: 4465-4474.
117. Zeng H, Qin L, Zhao D, Tan X, Manseau EJ, Van Hoang M, Senger DR, Brown LF, Nagy JA, Dvorak HF. 2006. Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med 203: 719-729.
118. Zhong M, Carney DH, Jo H, Boyan BD, Schwartz Z. 2010. Inorganic phosphate induces mammalian growth plate chondrocyte apoptosis in a mitochondrial pathway involving nitric oxide and JNK MAP kinase. Calcif Tissue Int 88: 96-108.